Neomycin Polymyxin B Sulfates And Dexamethasone
Product Images NDC 57319-347

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Neomycin Polymyxin B Sulfates And Dexamethasone (NDC 57319-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexamethasone (structural Formula) (61b2cb3a 9512 48a0 A01d 2cacebeae7fe 01)

FDA Label Image

Neomycin Sulfate (structural Formula) (61b2cb3a 9512 48a0 A01d 2cacebeae7fe 02)

FDA Label Image

Polymyxin B Sulfate (structural Formula) (61b2cb3a 9512 48a0 A01d 2cacebeae7fe 03)

FDA Label Image

Neomycin And Polymyxin B Sulfates And Dexamethasone Ophthalmic Suspension Usp (sterile) (label, 5 mL (Phoenix))

Neomycin And Polymyxin B Sulfates And Dexamethasone Ophthalmic Suspension Usp (sterile) (label, 5 mL (Phoenix))
This text appears to be a medication label with dosage instructions, ingredients, and storage information for a product containing neomycin, polymyxin B sulfate, and dexamethasone. The medication should be shaken before use and stored upright between 15°C to 30°C (59°F to 86°F). The label includes a warning not to use if the neckband is not intact. The product was manufactured for Phoenix Ml by Bausch & Lomb Incorporated in Tampa, Florida.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.